Erasca (ERAS) Other financing activities (2020 - 2026)
Erasca (ERAS) posted Other financing activities of $2.0 million for Q1 2026, up 667.84% on a QoQ basis from $255000.0 in Q4 2025, and up 5833.33% year-over-year from $33000.0 in Q1 2025.
Erasca (ERAS) Other financing activities (2020 - 2026) Analysis & Trends
Erasca's Other financing activities history runs 7 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Other financing activities rose 5833.33% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 171.83% YoY) and the FY2025 annual result came in at $372000.0, down 55.5% from the prior year.
- Other financing activities was $2.0 million for Q1 2026 at Erasca, up from $255000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $43.6 million in Q2 2024 and bottomed at -$43.2 million in Q3 2024.
- A 5-year average of $333823.5 and a median of $193000.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 35648.36% in 2024, while the deepest fall reached 617200.0% in 2024.
- Erasca's Other financing activities stood at $742000.0 in 2022, then slumped by 73.99% to $193000.0 in 2023, then soared by 105.18% to $396000.0 in 2024, then sank by 35.61% to $255000.0 in 2025, then jumped by 667.84% to $2.0 million in 2026.
- Business Quant data shows ERAS's Other financing activities at $2.0 million in Q1 2026, $255000.0 in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 Mn |
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 396,000.00 |
| Dec 31, 2024 | 396,000.00 |
| Sep 30, 2024 | -43.20 Mn |
| Sep 30, 2024 | -43.20 Mn |
| Jun 30, 2024 | 43.61 Mn |
| Jun 30, 2024 | 43.61 Mn |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 193,000.00 |
| Dec 31, 2023 | 193,000.00 |